Cargando…

Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review

OBJECTIVE: Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Beni, Kumar, Ashwin, Verma, Nikita, Agrawal, Ankit, Yesilyaprak, Abdullah, Furqan, Muhammad M, Mahalwar, Gauranga, Berglund, Felix, Manna, Sayan, Schleicher, Mary, Raeisi-Giglou, Pejman, Nasser, Mohamed, Jabri, Ahmad, Wang, Tom Kai Ming, Klein, Allan L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423526/
https://www.ncbi.nlm.nih.gov/pubmed/36702544
http://dx.doi.org/10.1136/heartjnl-2022-321798
_version_ 1785089472020348928
author Verma, Beni
Kumar, Ashwin
Verma, Nikita
Agrawal, Ankit
Yesilyaprak, Abdullah
Furqan, Muhammad M
Mahalwar, Gauranga
Berglund, Felix
Manna, Sayan
Schleicher, Mary
Raeisi-Giglou, Pejman
Nasser, Mohamed
Jabri, Ahmad
Wang, Tom Kai Ming
Klein, Allan L
author_facet Verma, Beni
Kumar, Ashwin
Verma, Nikita
Agrawal, Ankit
Yesilyaprak, Abdullah
Furqan, Muhammad M
Mahalwar, Gauranga
Berglund, Felix
Manna, Sayan
Schleicher, Mary
Raeisi-Giglou, Pejman
Nasser, Mohamed
Jabri, Ahmad
Wang, Tom Kai Ming
Klein, Allan L
author_sort Verma, Beni
collection PubMed
description OBJECTIVE: Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteristics, management and outcomes. METHODS: We performed a literature search and identified cases of patients with CPE from 1946 until May 2021 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We identified relevant articles for pooled analyses of clinical, diagnostic and outcome data. RESULTS: A total of 95 articles with 98 patients were identified. Patient demographics demonstrated male predominance (55%), with a mean age of 37±15 years. Time from symptom onset to diagnosis was 5 (Q1 4.5, Q3 14) days, with 74% of patients symptomatic on presentation. Idiopathic CPE (60%) was the most common aetiology. Cardiac tamponade secondary to CPE was seen in 38% of cases. Pericardial fluid analysis was required in 94% of cases. Lymphangiography identified the leakage site in 59% of patients. Medical therapy (total parenteral nutrition, medium-chain triglycerides or octreotide) was undertaken in 63% of cases. In our cohort, 32% progressed towards surgical intervention. During a median follow-up of 180 (Q1 180, Q3 377) days, CPE recurred in 16% of cases. Of the patients with recurrence, 10% were rehospitalised. CONCLUSION: CPE tends to develop in younger patients and may cause serious complications. Many patients fail medical therapy, thereby requiring surgical intervention. Although overall mortality is low, associated morbidities warrant close follow-up and possible reintervention and hospitalisations.
format Online
Article
Text
id pubmed-10423526
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-104235262023-08-14 Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review Verma, Beni Kumar, Ashwin Verma, Nikita Agrawal, Ankit Yesilyaprak, Abdullah Furqan, Muhammad M Mahalwar, Gauranga Berglund, Felix Manna, Sayan Schleicher, Mary Raeisi-Giglou, Pejman Nasser, Mohamed Jabri, Ahmad Wang, Tom Kai Ming Klein, Allan L Heart Systematic Review OBJECTIVE: Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteristics, management and outcomes. METHODS: We performed a literature search and identified cases of patients with CPE from 1946 until May 2021 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We identified relevant articles for pooled analyses of clinical, diagnostic and outcome data. RESULTS: A total of 95 articles with 98 patients were identified. Patient demographics demonstrated male predominance (55%), with a mean age of 37±15 years. Time from symptom onset to diagnosis was 5 (Q1 4.5, Q3 14) days, with 74% of patients symptomatic on presentation. Idiopathic CPE (60%) was the most common aetiology. Cardiac tamponade secondary to CPE was seen in 38% of cases. Pericardial fluid analysis was required in 94% of cases. Lymphangiography identified the leakage site in 59% of patients. Medical therapy (total parenteral nutrition, medium-chain triglycerides or octreotide) was undertaken in 63% of cases. In our cohort, 32% progressed towards surgical intervention. During a median follow-up of 180 (Q1 180, Q3 377) days, CPE recurred in 16% of cases. Of the patients with recurrence, 10% were rehospitalised. CONCLUSION: CPE tends to develop in younger patients and may cause serious complications. Many patients fail medical therapy, thereby requiring surgical intervention. Although overall mortality is low, associated morbidities warrant close follow-up and possible reintervention and hospitalisations. BMJ Publishing Group 2023-09 2023-01-26 /pmc/articles/PMC10423526/ /pubmed/36702544 http://dx.doi.org/10.1136/heartjnl-2022-321798 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Systematic Review
Verma, Beni
Kumar, Ashwin
Verma, Nikita
Agrawal, Ankit
Yesilyaprak, Abdullah
Furqan, Muhammad M
Mahalwar, Gauranga
Berglund, Felix
Manna, Sayan
Schleicher, Mary
Raeisi-Giglou, Pejman
Nasser, Mohamed
Jabri, Ahmad
Wang, Tom Kai Ming
Klein, Allan L
Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review
title Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review
title_full Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review
title_fullStr Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review
title_full_unstemmed Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review
title_short Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review
title_sort clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423526/
https://www.ncbi.nlm.nih.gov/pubmed/36702544
http://dx.doi.org/10.1136/heartjnl-2022-321798
work_keys_str_mv AT vermabeni clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT kumarashwin clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT vermanikita clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT agrawalankit clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT yesilyaprakabdullah clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT furqanmuhammadm clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT mahalwargauranga clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT berglundfelix clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT mannasayan clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT schleichermary clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT raeisigigloupejman clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT nassermohamed clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT jabriahmad clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT wangtomkaiming clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview
AT kleinallanl clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview